Shanghai Journal of Stomatology ›› 2022, Vol. 31 ›› Issue (1): 24-28.doi: 10.19439/j.sjos.2022.01.005

• Original Articles • Previous Articles     Next Articles

Effect of strontium ranelate on chondrogenic differentiation of rat bone mesenchymal stem cells

YU Hao1,2, LIU Yan1,2, YANG Xiang-wen1,2, ZHANG Fan1,2, HE Jia-jing1,2, ZHONG Qun1,2, GUO Xiao-jing1,2   

  1. 1. Shanghai Stomatological Hospital & School of Stomatology, Fudan University. Shanghai 200001;
    2. Shanghai Key Laboratory of Craniomaxillofacial Development and Diseases, Fudan University. Shanghai 200001, China
  • Received:2020-08-27 Revised:2020-11-15 Online:2022-02-25 Published:2022-03-10

Abstract: PURPOSE: The aim of present study was to explore the effect of strontium ranelate (SrR) on the proliferation and chondrogenic differentiation of rat bone mesenchymal stem cells (BMSCs). METHODS: Rat BMSCs were isolated and cultured in chondrogenic differentiation medium containing 0.25-2.0 mmol/L strontium ranelate. CCK-8 assay was used to study the influence of cell proliferation. Toluidine blue staining and alizarin blue staining were used to observe chondrogenic differentiation. Quantitative hydroxyproline (Hyp) activity assay was conducted. PCR and Western blots were used to detect the expression of related genes and proteins. Statistical analysis was performed using SPSS 22.0 software package. RESULTS: 0.25 mmol/L strontium ranelate did not inhibit the proliferation of BMSCs and promote the expression of chondroitin sulfate and proteoglycan. Hyp assay showed a higher content of collagen fibers in extracellular matrix in 0.25 mmol/L SrR treatment group. PCR and WB also showed up-regulated expression of Sox-9, Col-Ⅱ gene and protein, Aggrecan protein, and suppressed expression of MMP-9 gene. CONCLUSIONS: 0.25 mmol/L SrR could significantly promote chondrogenic differentiation of BMSCs.

Key words: Strontium Ranelate, Bone mesenchymal stem cells, Chondrogenic Differentiation

CLC Number: